Roche Registers Fresh Win For New Flu Drug
Executive Summary
Ahead of an FDA decision scheduled for December 24, the Swiss major's baloxivir has improved influenza symptoms versus placebo, and to a lesser extent Roche's own Tamiflu, in people at high risk of serious complications from the virus.